UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Flashback Foreword: Radical Cystectomy in the Treatment of Bladder Cancer

Journal of clinical oncology, 2023-08, Vol.41 (22), p.3769-3770

Bosl, George J

2023

Volltextzugriff (PDF)

Reduced proficiency in homologous recombination underlies the high sensitivity of embryonal carcinoma testicular germ cell tumors to Cisplatin and poly (adp-ribose) polymerase inhibition

PloS one, 2012-12, Vol.7 (12), p.e51563

2012

Volltextzugriff (PDF)

Long-Term and Late Effects of Germ Cell Testicular Cancer Treatment and Implications for Follow-Up

Journal of clinical oncology, 2012-10, Vol.30 (30), p.3752-3763

2012

Volltextzugriff (PDF)

Time to publication of oncology trials and why some trials are never published

PloS one, 2017-09, Vol.12 (9), p.e0184025-e0184025

2017

Volltextzugriff (PDF)

Scientific Review of Phase I Protocols With Novel Dose-Escalation Designs: How Much Information Is Needed?

Journal of clinical oncology, 2015-07, Vol.33 (19), p.2221-2225

2015

Volltextzugriff (PDF)

Medical treatment of advanced testicular cancer

JAMA : the journal of the American Medical Association, 2008-02, Vol.299 (6), p.672

2008

Volltextzugriff (PDF)

Optimal management of clinical stage I testis cancer: one size does not fit all

Journal of clinical oncology, 2013-10, Vol.31 (28), p.3477-3479

2013

Volltextzugriff (PDF)

Altering the Natural History of Surgical Relapse in Testicular Cancer: Suboptimal Surgery and Pneumoperitoneum

European urology, 2019-11, Vol.76 (5), p.612-614

2019

Volltextzugriff (PDF)

TI-CE High-Dose Chemotherapy for Patients With Previously Treated Germ Cell Tumors: Results and Prognostic Factor Analysis

Journal of clinical oncology, 2010-04, Vol.28 (10), p.1706-1713

2010

Volltextzugriff (PDF)

CT findings of chemotherapy-induced toxicity: what radiologists need to know about the clinical and radiologic manifestations of chemotherapy toxicity

Radiology, 2011-01, Vol.258 (1), p.41-56

2011

Volltextzugriff (PDF)

Combination of Paclitaxel, Ifosfamide, and Cisplatin Is an Effective Second-Line Therapy for Patients With Relapsed Testicular Germ Cell Tumors

Journal of clinical oncology, 2005-09, Vol.23 (27), p.6549-6555

2005

Volltextzugriff (PDF)

Reply to L.H. Einhorn et al

Journal of clinical oncology, 2020-09, Vol.38 (26), p.3074-3075

2020

Volltextzugriff (PDF)

Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors

Journal of clinical oncology, 2016-11, Vol.34 (33), p.4000-4007

2016

Volltextzugriff (PDF)

Paclitaxel, Ifosfamide, and Cisplatin as Initial Salvage Chemotherapy for Germ Cell Tumors: Long-Term Follow-Up and Outcomes for Favorable- and Unfavorable-Risk Disease

Journal of clinical oncology, 2024-09, Vol.42 (26), p.3130-3139

2024

Volltextzugriff (PDF)

Phase III Randomized Trial of Conventional-Dose Chemotherapy With or Without High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Rescue As First-Line Treatment for Patients With Poor-Prognosis Metastatic Germ Cell Tumors

Journal of clinical oncology, 2007-01, Vol.25 (3), p.247-256

2007

Volltextzugriff (PDF)

Practice Makes Perfect: The Rest of the Story in Testicular Cancer as a Model Curable Neoplasm

Journal of clinical oncology, 2017-11, Vol.35 (31), p.3525-3528

2017

Volltextzugriff (PDF)

Outcomes After Multidisciplinary Management of Primary Mediastinal Germ Cell Tumors

Annals of surgery, 2021-12, Vol.274 (6), p.e1099-e1107

2021

Volltextzugriff (PDF)

Presence of Somatic Mutations within PIK3CA, AKT, RAS, and FGFR3 but not BRAF in Cisplatin-Resistant Germ Cell Tumors

Clinical cancer research, 2014-07, Vol.20 (14), p.3712-3720

2014

Volltextzugriff (PDF)

Development and Validation of a Gene-Based Model for Outcome Prediction in Germ Cell Tumors Using a Combined Genomic and Expression Profiling Approach

PloS one, 2015-12, Vol.10 (12), p.e0142846-e0142846

2015

Volltextzugriff (PDF)

Impact of Teratoma on the Cumulative Incidence of Disease-Related Death in Patients With Advanced Germ Cell Tumors

Journal of clinical oncology, 2019-09, Vol.37 (26), p.2329-2337

2019

Volltextzugriff (PDF)

Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor

The Journal of clinical investigation, 2020-12, Vol.130 (12), p.6668-6676

2020

Volltextzugriff (PDF)

Adjuvant Chemotherapy With Etoposide Plus Cisplatin for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumors

Journal of clinical oncology, 2020-04, Vol.38 (12), p.1332-1337

2020

Volltextzugriff (PDF)

Four Cycles of Etoposide plus Cisplatin for Patients with Good‐Risk Advanced Germ Cell Tumors

The oncologist (Dayton, Ohio), 2021-06, Vol.26 (6), p.483-491

2021

Volltextzugriff (PDF)

Carboplatin in clinical stage I seminoma: too much and too little at the same time

Journal of clinical oncology, 2011-03, Vol.29 (8), p.949-952

2011

Volltextzugriff (PDF)

Clinical Outcomes of Local and Metastatic Testicular Sex Cord-Stromal Tumors

The Journal of urology, 2014-08, Vol.192 (2), p.415-419

2014

Volltextzugriff (PDF)

1 – 25 von 385

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(361)
Mit Volltextzugriff
(283)

Publikationsform

Sprache

Englisch
(384)
Japanisch
(24)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(262)
Science & Technology
(255)
Life Sciences & Biomedicine
(251)
Male
(216)
Oncology
(178)
Biological And Medical Sciences
(151)
Medical Sciences
(147)
Adult
(135)
Middle Aged
(98)
Tumors
(85)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(83)
Testicular Neoplasms - Pathology
(78)
Testicular Neoplasms - Drug Therapy
(75)
Adolescent
(62)
Neoplasms, Germ Cell And Embryonal - Drug Therapy
(62)
Chemotherapy
(61)
Pharmacology. Drug Treatments
(58)
Female
(56)
Antineoplastic Agents
(53)
Prognosis
(51)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Flashback Foreword: Radical Cystectomy in the Treatment of Bladder Cancer

Reduced proficiency in homologous recombination underlies the high sensitivity of embryonal carcinoma testicular germ cell tumors to Cisplatin and poly (adp-ribose) polymerase inhibition

Long-Term and Late Effects of Germ Cell Testicular Cancer Treatment and Implications for Follow-Up

Time to publication of oncology trials and why some trials are never published

Scientific Review of Phase I Protocols With Novel Dose-Escalation Designs: How Much Information Is Needed?

Medical treatment of advanced testicular cancer

Optimal management of clinical stage I testis cancer: one size does not fit all

Altering the Natural History of Surgical Relapse in Testicular Cancer: Suboptimal Surgery and Pneumoperitoneum

TI-CE High-Dose Chemotherapy for Patients With Previously Treated Germ Cell Tumors: Results and Prognostic Factor Analysis

CT findings of chemotherapy-induced toxicity: what radiologists need to know about the clinical and radiologic manifestations of chemotherapy toxicity

Combination of Paclitaxel, Ifosfamide, and Cisplatin Is an Effective Second-Line Therapy for Patients With Relapsed Testicular Germ Cell Tumors

Reply to L.H. Einhorn et al

Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors

Paclitaxel, Ifosfamide, and Cisplatin as Initial Salvage Chemotherapy for Germ Cell Tumors: Long-Term Follow-Up and Outcomes for Favorable- and Unfavorable-Risk Disease

Phase III Randomized Trial of Conventional-Dose Chemotherapy With or Without High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Rescue As First-Line Treatment for Patients With Poor-Prognosis Metastatic Germ Cell Tumors

Practice Makes Perfect: The Rest of the Story in Testicular Cancer as a Model Curable Neoplasm

Outcomes After Multidisciplinary Management of Primary Mediastinal Germ Cell Tumors

Presence of Somatic Mutations within PIK3CA, AKT, RAS, and FGFR3 but not BRAF in Cisplatin-Resistant Germ Cell Tumors

Development and Validation of a Gene-Based Model for Outcome Prediction in Germ Cell Tumors Using a Combined Genomic and Expression Profiling Approach

Impact of Teratoma on the Cumulative Incidence of Disease-Related Death in Patients With Advanced Germ Cell Tumors

Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor

Adjuvant Chemotherapy With Etoposide Plus Cisplatin for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumors

Four Cycles of Etoposide plus Cisplatin for Patients with Good‐Risk Advanced Germ Cell Tumors

Carboplatin in clinical stage I seminoma: too much and too little at the same time

Clinical Outcomes of Local and Metastatic Testicular Sex Cord-Stromal Tumors

Suchergebnisse filtern